Malignancy After Heart Transplantation

Po Lin Chen, Hsiao Huang Chang, I. Ming Chen, Shiau Ting Lai, Chun Che Shih, Zen Chung Weng, Yuan Chen Hsieh, An Hang Yang

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: The purpose of this study was to assess the incidence and type of malignancies after heart transplantation at a medical institute in Taiwan. Methods: From January 1987 to December 2008, a total of 66 patients who survived more than 30 days after transplantation were enrolled in this study. Results: Of the 66 heart transplant recipients, 8 (12.1%) post-transplant malignancies were diagnosed: 5 post- transplant lymphoproliferative diseases (PTLD), 1 prostate cancer, 1 lung cancer, and 1 squamous cell carcinoma of the cheek. The clinical presentations were diverse, and the diagnoses were confirmed by biopsy. Only 1 patient died of PTLD and subsequent multiple organ failure. Conclusion: Cancer is a limiting factor for long-term survival after heart transplantation. The most common type in this study was PTLD. Early detection and aggressive treatment results in good response and preserves the allograft.

Original languageEnglish
Pages (from-to)588-593
Number of pages6
JournalJournal of the Chinese Medical Association
Volume72
Issue number11
DOIs
Publication statusPublished - Nov 1 2009
Externally publishedYes

Fingerprint

Heart Transplantation
Transplants
Lung Neoplasms
Neoplasms
Multiple Organ Failure
Cheek
Taiwan
Allografts
Squamous Cell Carcinoma
Prostatic Neoplasms
Transplantation
Biopsy
Survival
Incidence
Therapeutics

Keywords

  • heart transplantation
  • malignancy
  • post-transplant lymphoproliferative disorder

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chen, P. L., Chang, H. H., Chen, I. M., Lai, S. T., Shih, C. C., Weng, Z. C., ... Yang, A. H. (2009). Malignancy After Heart Transplantation. Journal of the Chinese Medical Association, 72(11), 588-593. https://doi.org/10.1016/S1726-4901(09)70434-4

Malignancy After Heart Transplantation. / Chen, Po Lin; Chang, Hsiao Huang; Chen, I. Ming; Lai, Shiau Ting; Shih, Chun Che; Weng, Zen Chung; Hsieh, Yuan Chen; Yang, An Hang.

In: Journal of the Chinese Medical Association, Vol. 72, No. 11, 01.11.2009, p. 588-593.

Research output: Contribution to journalArticle

Chen, PL, Chang, HH, Chen, IM, Lai, ST, Shih, CC, Weng, ZC, Hsieh, YC & Yang, AH 2009, 'Malignancy After Heart Transplantation', Journal of the Chinese Medical Association, vol. 72, no. 11, pp. 588-593. https://doi.org/10.1016/S1726-4901(09)70434-4
Chen, Po Lin ; Chang, Hsiao Huang ; Chen, I. Ming ; Lai, Shiau Ting ; Shih, Chun Che ; Weng, Zen Chung ; Hsieh, Yuan Chen ; Yang, An Hang. / Malignancy After Heart Transplantation. In: Journal of the Chinese Medical Association. 2009 ; Vol. 72, No. 11. pp. 588-593.
@article{e6a83436402a4b96b96230db70e1ccc7,
title = "Malignancy After Heart Transplantation",
abstract = "Background: The purpose of this study was to assess the incidence and type of malignancies after heart transplantation at a medical institute in Taiwan. Methods: From January 1987 to December 2008, a total of 66 patients who survived more than 30 days after transplantation were enrolled in this study. Results: Of the 66 heart transplant recipients, 8 (12.1{\%}) post-transplant malignancies were diagnosed: 5 post- transplant lymphoproliferative diseases (PTLD), 1 prostate cancer, 1 lung cancer, and 1 squamous cell carcinoma of the cheek. The clinical presentations were diverse, and the diagnoses were confirmed by biopsy. Only 1 patient died of PTLD and subsequent multiple organ failure. Conclusion: Cancer is a limiting factor for long-term survival after heart transplantation. The most common type in this study was PTLD. Early detection and aggressive treatment results in good response and preserves the allograft.",
keywords = "heart transplantation, malignancy, post-transplant lymphoproliferative disorder",
author = "Chen, {Po Lin} and Chang, {Hsiao Huang} and Chen, {I. Ming} and Lai, {Shiau Ting} and Shih, {Chun Che} and Weng, {Zen Chung} and Hsieh, {Yuan Chen} and Yang, {An Hang}",
year = "2009",
month = "11",
day = "1",
doi = "10.1016/S1726-4901(09)70434-4",
language = "English",
volume = "72",
pages = "588--593",
journal = "Journal of the Chinese Medical Association",
issn = "1726-4901",
publisher = "Elsevier Taiwan LLC",
number = "11",

}

TY - JOUR

T1 - Malignancy After Heart Transplantation

AU - Chen, Po Lin

AU - Chang, Hsiao Huang

AU - Chen, I. Ming

AU - Lai, Shiau Ting

AU - Shih, Chun Che

AU - Weng, Zen Chung

AU - Hsieh, Yuan Chen

AU - Yang, An Hang

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Background: The purpose of this study was to assess the incidence and type of malignancies after heart transplantation at a medical institute in Taiwan. Methods: From January 1987 to December 2008, a total of 66 patients who survived more than 30 days after transplantation were enrolled in this study. Results: Of the 66 heart transplant recipients, 8 (12.1%) post-transplant malignancies were diagnosed: 5 post- transplant lymphoproliferative diseases (PTLD), 1 prostate cancer, 1 lung cancer, and 1 squamous cell carcinoma of the cheek. The clinical presentations were diverse, and the diagnoses were confirmed by biopsy. Only 1 patient died of PTLD and subsequent multiple organ failure. Conclusion: Cancer is a limiting factor for long-term survival after heart transplantation. The most common type in this study was PTLD. Early detection and aggressive treatment results in good response and preserves the allograft.

AB - Background: The purpose of this study was to assess the incidence and type of malignancies after heart transplantation at a medical institute in Taiwan. Methods: From January 1987 to December 2008, a total of 66 patients who survived more than 30 days after transplantation were enrolled in this study. Results: Of the 66 heart transplant recipients, 8 (12.1%) post-transplant malignancies were diagnosed: 5 post- transplant lymphoproliferative diseases (PTLD), 1 prostate cancer, 1 lung cancer, and 1 squamous cell carcinoma of the cheek. The clinical presentations were diverse, and the diagnoses were confirmed by biopsy. Only 1 patient died of PTLD and subsequent multiple organ failure. Conclusion: Cancer is a limiting factor for long-term survival after heart transplantation. The most common type in this study was PTLD. Early detection and aggressive treatment results in good response and preserves the allograft.

KW - heart transplantation

KW - malignancy

KW - post-transplant lymphoproliferative disorder

UR - http://www.scopus.com/inward/record.url?scp=74249087488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74249087488&partnerID=8YFLogxK

U2 - 10.1016/S1726-4901(09)70434-4

DO - 10.1016/S1726-4901(09)70434-4

M3 - Article

C2 - 19948436

AN - SCOPUS:74249087488

VL - 72

SP - 588

EP - 593

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

SN - 1726-4901

IS - 11

ER -